Trevi Therapeutics, Inc. (TRVI)
13.14
-0.04
(-0.30%)
USD |
NASDAQ |
Oct 07, 16:00
13.14
0.00 (0.00%)
After-Hours: 20:00
Trevi Therapeutics Market Cap : 1.871B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 1.871B |
| October 06, 2026 | 1.877B |
| October 05, 2026 | 1.954B |
| October 02, 2026 | 1.981B |
| October 01, 2026 | 2.020B |
| September 30, 2026 | 2.039B |
| September 29, 2026 | 2.054B |
| September 28, 2026 | 2.051B |
| September 25, 2026 | 2.052B |
| September 24, 2026 | 2.090B |
| September 23, 2026 | 2.059B |
| September 22, 2026 | 2.170B |
| September 21, 2026 | 2.121B |
| September 18, 2026 | 2.129B |
| September 17, 2026 | 2.166B |
| September 16, 2026 | 2.138B |
| September 15, 2026 | 2.142B |
| September 14, 2026 | 2.263B |
| September 11, 2026 | 2.264B |
| September 10, 2026 | 2.266B |
| September 09, 2026 | 2.370B |
| September 08, 2026 | 2.396B |
| September 04, 2026 | 2.458B |
| September 03, 2026 | 2.430B |
| September 02, 2026 | 2.428B |
| Date | Value |
|---|---|
| September 01, 2026 | 2.360B |
| August 31, 2026 | 2.364B |
| August 28, 2026 | 2.391B |
| August 27, 2026 | 2.558B |
| August 26, 2026 | 2.552B |
| August 25, 2026 | 2.556B |
| August 24, 2026 | 2.575B |
| August 21, 2026 | 2.558B |
| August 20, 2026 | 2.599B |
| August 19, 2026 | 2.679B |
| August 18, 2026 | 2.683B |
| August 17, 2026 | 2.632B |
| August 14, 2026 | 2.629B |
| August 13, 2026 | 2.585B |
| August 12, 2026 | 2.525B |
| August 11, 2026 | 2.535B |
| August 10, 2026 | 2.535B |
| August 07, 2026 | 2.636B |
| August 06, 2026 | 2.635B |
| August 05, 2026 | 2.656B |
| August 04, 2026 | 2.670B |
| August 03, 2026 | 2.299B |
| July 31, 2026 | 2.344B |
| July 30, 2026 | 2.363B |
| July 29, 2026 | 2.323B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.652B |
| Corcept Therapeutics, Inc. | 12.91B |
| Veru, Inc. | 41.94M |
| Johnson & Johnson | 622.41B |
| Eli Lilly & Co. | 1.119T |
Market Cap Related Metrics
| Price to Book Value | 5.821 |
| Price | 13.14 |
| Earnings Yield | -2.61% |